Induced sputum in asthma and COPD: meassuring type and inflammation activity Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006
Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020
Airway inflammation: assessment of neutrophil apoptosis in induced sputum Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005
Chronic sputum production in COPD is a marker for airway inflammation and colonisation Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity? Source: Eur Respir J 2001; 18: Suppl. 33, 247s Year: 2001
Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013
Lung function and bacterial pathogens in sputum of patients with acute exacerbation of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 408s Year: 2004
Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005
Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006
Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007
Chronic cough and sputum production: a clinical COPD phenotype? Source: Eur Respir J 2012; 40: 4-6 Year: 2012
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002
Levofloxacin prevents eosinophil activation and asthma exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 207s Year: 2006
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003
Role of sputum eosinophil levels in the assessment of asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004